(Total Views: 140)
Posted On: 08/15/2025 12:52:08 PM
Post# of 108921

$CVM CEL-SCI’s Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline
https://www.businesswire.com/news/home/202508...A-Timeline
https://www.businesswire.com/news/home/202508...A-Timeline

